Key Points
- Ingevity SVP Terrance Dyer sold 496 shares on May 28 at an average price of $68.49, totaling about $33,971. After the sale, he still owned 7,202 shares, a 6.44% reduction in his stake.
- The company beat earnings expectations in its latest quarterly report, posting $1.15 EPS versus the $0.84 consensus and revenue of $258 million, up 4.1% year over year.
- Analyst sentiment is mixed but leans cautious, with MarketBeat showing an average rating of “Hold” and an average price target of $80.00, while individual firms have ranged from sell to buy and strong-buy calls.
Ingevity Corporation (NYSE:NGVT - Get Free Report) SVP Terrance Dyer sold 496 shares of the firm's stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Ingevity Stock Performance
Shares of NGVT opened at $66.41 on Tuesday. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83. The firm has a market cap of $2.31 billion, a PE ratio of -18.71 and a beta of 1.24. The company's 50 day simple moving average is $71.66 and its 200-day simple moving average is $65.98. Ingevity Corporation has a 12-month low of $39.74 and a 12-month high of $79.29.
Ingevity (NYSE:NGVT - Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.31. The business had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, equities analysts predict that Ingevity Corporation will post 5.05 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on NGVT. Wells Fargo & Company lifted their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an "equal weight" rating in a research report on Friday, February 27th. Wall Street Zen upgraded shares of Ingevity from a "hold" rating to a "strong-buy" rating in a research report on Saturday, May 9th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Ingevity in a research report on Tuesday, April 21st. Jefferies Financial Group reiterated a "buy" rating and issued a $82.00 price objective on shares of Ingevity in a research report on Thursday, February 26th. Finally, BMO Capital Markets reiterated an "outperform" rating and issued a $83.00 price objective on shares of Ingevity in a research report on Monday, March 2nd. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $80.00.
View Our Latest Research Report on Ingevity
Institutional Investors Weigh In On Ingevity
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Assetmark Inc. lifted its holdings in Ingevity by 9.6% in the first quarter. Assetmark Inc. now owns 1,584 shares of the company's stock valued at $113,000 after acquiring an additional 139 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in Ingevity by 3.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company's stock valued at $418,000 after acquiring an additional 238 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Ingevity by 15.7% in the third quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company's stock valued at $103,000 after acquiring an additional 254 shares during the period. Advisory Services Network LLC raised its stake in shares of Ingevity by 4.4% during the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company's stock worth $383,000 after buying an additional 293 shares during the last quarter. Finally, Amundi raised its stake in shares of Ingevity by 4.8% during the 3rd quarter. Amundi now owns 6,626 shares of the company's stock worth $364,000 after buying an additional 302 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company's stock.
About Ingevity
(
Get Free Report)
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
